Get started
Author

Hung-En Huang

Romosozumab versus teriparatide and risk of all-cause mortality in patients with osteoporosis: a real-world propensity score-matched cohort study
2026 · Sung Huang Laurent Tsai, Yu Hsuan Chen, et al. · Osteoporosis International · 8
Sustained and attenuated effects of transitioning from supervised to self-managed resistance training in older adults with type 2 diabetes and sarcopenia: a randomized controlled trial
2026 · Yueh-Chu Wu, Li-Na Liao, et al. · Acta Diabetologica · 1
PDF
Fracture burden, not a T-score, should define access to osteoanabolic therapy
2026 · Sung Huang Laurent Tsai, Yu Hsuan Chen, et al. · Osteoporosis International
Cardiovascular risk factors as a relative, not absolute, contraindication to romosozumab: real-world evidence in support of Tsai et al.
2026 · Sung Huang Laurent Tsai, Yu Hsuan Chen, et al. · Osteoporosis International
Comparison of Acupuncture and Lumbar Traction for Lumbar Disc Herniation and Subsequent Risk of Lumbar Fusion or Discectomy: A Retrospective Cohort Study
2026 · Sung Huang Laurent Tsai, Ming-Hao Chen, et al. · Journal of Pain Research
PDF
Comparative Effectiveness and Cardiovascular Safety of Romosozumab versus Teriparatide in Osteoporosis Patients with CKD
2026 · Cheng-Hsien Hung, Fu-Yu Yang, et al. · Clinical Journal of the American Society of Nephrology
Comparative Real-World Outcomes of OnabotulinumtoxinA and CGRP Monoclonal Antibodies in Chronic Migraine
2026 · Chun-Fu Lin, Chen-Chih Chung, et al. · Journal of Clinical Medicine
PDF
Works count: 7
Citation count: 9
H-index: 1
I10-index:
Year
Topic
Type